参考文献/References:
[1] MARKWART R,SAITO H,HARDER T,et al.Epidemiology and burden of sepsis acquired in hospitals and intensive care units:A systematic review and meta-analysis[J].Intensive Care Med,2020,46(8):1536-1551.
[2] RUDD K E,JOHNSON S C,AGESA K M,et al.Global,regional,and national sepsis incidence and mortality,1990-2017:Analysis for the global burden of disease study[J].Lancet,2020,395(10219):200-211.
[3] RHODES A,EVANS L E,ALHAZZANI W,et al.Surviving sepsis campaign:International guidelines for management of sepsis and septic shock:2016[J].Crit Care Med,2017,45(3):486-552.
[4] FLEISCHMANN C,THOMAS-RUEDDEL D O,HARTMANN M,et al.Hospital incidence and mortality rates of sepsis[J].Dtsch Arztebl Int,2016,113(10):159-166.
[5] NIE M W,HAN Y C,SHEN Z J,et al.Identification of circRNA and mRNA expression profiles and functional networks of vascular tissue in lipopolysaccharide-induced sepsis[J].J Cell Mol Med,2020,24(14):7915-7927.
[6] FLEISCHMANN-STRUZEK C,MELLHAMMAR L,ROSE N,et al.Incidence and mortality of hospital-and ICU-treated sepsis:Results from an updated and expanded systematic review and meta-analysis[J].Intensive Care Med,2020,46(8):1552-1562.
[7] MCBRIDE M A,PATIL T K,BOHANNON J K,et al.Immune checkpoints:Novel therapeutic targets to attenuate sepsis-induced immunosuppression[J].Front Immunol,2021,11:624272.
[8] HUANG M,CAI S,SU J.The pathogenesis of sepsis and potential therapeutic targets[J].Int J Mol Sci,2019,20(21):5376.
[9] CHOUSTERMAN B G,SWIRSKI F K,WEBER G F.Cytokine storm and sepsis disease pathogenesis[J].Semin Immunopathol,2017,39(5):517-528.
[10] ARINA P,SINGER M.Pathophysiology of sepsis[J].Curr Opin Anaesthesiol,2021,34(2):77-84.
[11] 钟敏林,周仙仕,李俊,等.血流感染脓毒症患者687例临床特征、中医证素分布及其与预后的相关性分析[J].陕西中医,2022,43(10):1392-1395.
[12] 谢琼燕,许环清,叶文,等.生物标志物预测脓毒症引发急性肾损伤临床研究[J].陕西医学杂志,2023,52(7):880-884.
[13] 吴泽华,李跃东,戴莹莹,等.降钙素原、C反应蛋白、白细胞计数和中性粒细胞比率在重症医学科脓毒症治疗预后判断中的临床价值[J].陕西医学杂志,2024,53(4):540-543.
[14] 商跃云,张慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,48(6):706-710.
[15] HERNÁNDEZ-AGUILAR A I,LUCIANO-VILLA C A,TELLO-FLORES V A,et al.Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved:A systematic review[J].Expert Rev Mol Diagn,2021,21(8):809-821.
[16] NA L,DING H,XING E,et al.Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21[J].J Clin Lab Anal,2020,34(4):e23123.
[17] VOLDERS P J,ANCKAERT J,VERHEGGEN K,et al.LNCipedia 5:Towards a reference set of human long non-coding RNAs[J].Nucleic Acids Res,2019,47(D1):D135-D139.
[18] KHORKOVA O,HSIAO J,WAHLESTEDT C.Basic biology and therapeutic implications of lncRNA[J].Adv Drug Deliv Rev,2015,87:15-24.
[19] JANDURA A,KRAUSE H M.The new RNA world:Growing evidence for long noncoding RNA functionality[J].Trends Genet,2017,33(10):665-676.
[20] FATICA A,BOZZONI I.Long non-coding RNAs:New players in cell differentiation and development[J].Nat Rev Genet,2014,15(1):7-21.
[21] YAO H,HAN B,ZHANG Y,et al.Non-coding RNAs and autophagy[J].Adv Exp Med Biol,2019,1206:199-220.
[22] SU Z,YANG Z,XU Y,et al.MicroRNAs in apoptosis,autophagy and necroptosis[J].Oncotarget,2015,6(11):8474-8490.
[23] WANG J,YAN S,YAMG J,et al.Non-coding RNAs in rheumatoid arthritis:From bench to bedside[J].Front Immunol,2020,10:3129.
[24] GHAFOURI-FARD S,SHOOREI H,TAHERI M.Non-coding RNAs participate in the ischemia-reperfusion injury[J].Biomed Pharmacother,2020,129:110419.
[25] WANG W,YANG N,WEN R,et al.Long noncoding RNA:Regulatory mechanisms and therapeutic potential in sepsis[J].Front Cell Infect Microbiol,2021,11:563126.
[26] ZHANG X,CUI Y,DING X,et al.Analysis of mRNA-lncRNA and mRNA-lncRNA-pathway co-expression networks based on WGCNA in developing pediatric sepsis[J].Bioengineered,2021,12(1):1457-1470.
[27] WANG X,GUO Z,WANG Z,et al.Diagnostic and predictive values of pyroptosis-related genes in sepsis[J].Front Immunol,2023,14:1105399.
[28] HUANG Q,WANG Y,HE F.Blood long non-coding RNA intersectin 1-2 is highly expressed and links with increased Th17 cells,inflammation,multiple organ dysfunction,and mortality risk in sepsis patients[J].J Clin Lab Anal,2022,36(4):e24330.
[29] LIU X,XU Y,WANG R,et al.A network-based algorithm for the identification of moonlighting noncoding RNAs and its application in sepsis[J].Brief Bioinform,2021,22(1):581-588.
[30] ZHOU Y,SUN L,ZHU M,et al.Effects and early diagnostic value of lncRNA H19 on sepsis-induced acute lung injury[J].Exp Ther Med,2022,23(4):279.
[31] HOLLENBERG S M,SINGER M.Pathophysiology of sepsis-induced cardiomyopathy[J].Nat Rev Cardiol,2021,18(6):424-434.
[32] 于杰,姚刚,赵岚,等.右美托咪定缓解脓毒症引起的心脏功能障碍的机制研究[J].医学信息,2023,36(6):77-80.
[33] BEESLEY S J,WEBER G,SARGE T,et al.Septic cardiomyopathy[J].Crit Care Med,2018,46(4):625-634.
[34] KAAIHNAN Y,ITO T,NAKAHARA M,et al.Sepsis-induced myocardial dysfunction:Pathophysiology and management[J].J Intensive Care,2016,4:22.
[35] ZHANG T N,GOODWIN J E,LIU B,et al.Characterization of long noncoding RNA and mRNA profiles in sepsis-induced myocardial depression[J].Mol Ther Nucleic Acids,2019,17:852-866.
[36] XU H,YE W,SHI B.LncRNA MALAT1 regulates USP22 expression through EZH2-mediated H3K27me3 modification to accentuate sepsis-induced myocardial dysfunction[J].Cardiovasc Toxicol,2022,22(9):813-830.
[37] CHEN W,GAO G,YAN M,et al.Long noncoding RNA MAPKAPK5-AS1 promoted lipopolysaccharide-induced inflammatory damage in the myocardium by sponging microRNA-124-3p/E2F3[J].Mol Med,2021,27(1):131.
[38] LIU L,YAN L N,SUI Z.MicroRNA-150 affects endoplasmic reticulum stress via MALAT1-miR-150 axis-mediated NF-κB pathway in LPS-challenged HUVECs and septic mice[J].Life Sci,2021,265:118744.
[39] WANG X,LI X L,QIN L J.The lncRNA XIST/miR-150-5p/c-Fos axis regulates sepsis-induced myocardial injury via TXNIP-modulated pyroptosis[J].Lab Invest,2021,101(9):1118-1129.
[40] GAO H,MA H,GAO M,et al.Long non-coding RNA GAS5 aggravates myocardial depression in mice with sepsis via the microRNA-449b/HMGB1 axis and the NF-κB signaling pathway[J].Biosci Rep,2021,41(4):BSR20201738.
[41] SONNEVILLE R,DE-MONTMOLLIN E,POUJADE J,et al.Potentially modifiable factors contributing to sepsis-associated encephalopathy[J].Intensive Care Med,2017,43(8):1075-1084.
[42] WEN J,LIU Y,ZHAN Z,et al.Comprehensive analysis of mRNAs,lncRNA and circRNAs in the early phase of microglial activation[J].Exp Ther Med,2021,22(6):1460.
[43] WEI X B,JIANG W Q,ZENG J H,et al.Exosome-derived lncRNA NEAT1 exacerbates sepsis-associated encephalopathy by promoting ferroptosis through regulating miR-9-5p/TFRC and GOT1 Axis[J].Mol Neurobiol,2022,59(3):1954-1969.
[44] LIU W Q,WANG Y J,ZHENG Y,et al.Effects of long non-coding RNA NEAT1 on sepsis-induced brain injuryin mice via NF-κB[J].Eur Rev Med Pharmacol Sci,2019,23(9):3933-3939.
[45] WANG L,CAO Q M.Long non-coding RNA XIST alleviates sepsis-induced acute kidney injury through inhibiting inflammation and cell apoptosis via regulating miR-155-5p/WWC1 axis[J].Kaohsiung J Med Sci,2022,38(1):6-17.
[46] HEI B,YUE C,SUN Y.Long noncoding RNA ZFAS1 protects HK-2 Cells against sepsis-induced injury through targeting the miR3723p/PPARα axis[J].J Healthc Eng,2022,2022:7768963.
[47] ZHANG X,HUANG Z,WANG Y,et al.Long non-coding RNA RMRP contributes to sepsis-induced acute kidney injury[J].Yonsei Med J,2021,62(3):262-273.
[48] 刘江正,宋德心,马丞飞,等.线粒体抗氧化剂MitoQ减轻氮芥诱导小鼠急性肝损伤[J].空军军医大学学报,2023,44(3):222-228.
[49] YANG Y,TIAN T,LI S,et al.LncRNA 220:A novel long non-coding RNA regulates autophagy and apoptosis in kupffer cells via the miR-5101/PI3K/AKT/mTOR axis in LPS-induced endotoxemic liver injury in mice[J].Int J Mol Sci,2023,24(13):11210.
[50] ZHAO Q,SHENG M F,WANG Y Y,et al.LncRNA Gm26917 regulates inflammatory response in macrophages by enhancing Annexin A1 ubiquitination in LPS-induced acute liver injury[J].Front Pharmacol,2022,13:975250.[51] CHEN L,KANG X,MENG X,et al.MALAT1-mediated EZH2 recruitment to the GFER promoter region curbs normal hepatocyte proliferation in acute liver injury[J].J Clin Transl Hepatol,2023,11(1):97-109.[52] ZHANG X,NING W,GAO G,et al.Bazedoxifene attenuates intestinal injuryin sepsis by suppressing the NF-κB/NLRP3 signaling pathways[J].Eur J Pharmacol,2023,947:175681.[53] CHEN Y L,XIE Y J,LIU Z M,et al.Omega-3 fatty acids impair miR-1-3p-dependent Notch3 down-regulation and alleviate sepsis-induced intestinal injury[J].Mol Med,2022,28(1):9.[54] HE X,DONG K,SHEN J,et al.The long noncoding RNA cardiac mesoderm enhancer-associated noncoding RNA(Carmn)is a critical regulator of gastrointestinal smooth muscle contractile function and motility[J].Gastroenterology,2023,165(1):71-87.
相似文献/References:
[1]李文军,于代华,宗 雷,等.脾多肽注射液对脓毒症患者血清炎症因子及免疫功能的影响*[J].陕西医学杂志,2019,(4):463.
LI Wenjun,YU Daihua,ZONG Lei,et al.Effect of spleen peptide injection on serum inflammatory factors and immune function in patients With Sepsis[J].,2019,(8):463.
[2]商跃云,张 慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,(6):706.
SHSNG Yueyun,ZHANG Hui,LIN Shuxiang,et al.Changes of immunoglobulin binding protein, activating transcription factor 6 and DNA-damage-inducible transcript 3 protein levels in CD4+T cells in children with sepsis[J].,2019,(8):706.
[3]田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510.
TIAN Yongchao..Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis[J].,2020,49(8):510.
[4]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(8):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
[5]肖武强,董 磊,吴先正△.急性胃肠损伤分级联合D-乳酸、内毒素水平测定对脓毒症患者预后的评估价值*[J].陕西医学杂志,2020,49(12):1577.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.010]
[6]易亭伍,梁 睿,宿向东.长链非编码RNA SNHG15通过miR-141-3p /KLF9机制调控鼻咽癌细胞增殖的实验研究[J].陕西医学杂志,2021,50(1):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]
YI Tingwu,LIANG Rui,SU Xiangdong.Study on long chain non-coding RNA SNHG15 regulating the proliferation of nasopharyngeal carcinoma cells through miR-141-3p/KLF9[J].,2021,50(8):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]
[7]张 瑜,王 娟.脓毒症并发急性呼吸窘迫综合征患者血清血管内皮钙黏蛋白、血管生成素2表达及与预后相关性研究[J].陕西医学杂志,2022,51(2):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
ZHANG Yu,WANG Juan.Expression of serum vascular endothelial cadherin and angiopoietin 2 in sepsis patients complicated with acute respiratory distress syndrome and their correlation with prognosis[J].,2022,51(8):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
[8]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(8):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[9]李博文,张心宇,刘 洋,等.肺腺癌患者血清长链非编码RNA miR155HG表达及意义[J].陕西医学杂志,2022,51(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.026]
LI Bowen,ZHANG Xinyu,LIU Yang,et al.Expression and significance of lncRNA miR155HG in serum of patients with lung adenocarcinoma[J].,2022,51(8):492.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.026]
[10]高 宾,王春花,李雅琪,等.长链非编码RNA在口腔鳞状细胞癌及其微环境中的作用研究进展[J].陕西医学杂志,2022,51(11):1458.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.033]